IDO1 and Huntington disease: Some studies have shown the efficacy of lipoic acid, dichloroacetate or IDO1 and IDO2 inhibitors by achieving a favorable prognosis in HD patients (Andreassen et al., 2001a; Andreassen et al., 2001b; Boros et al., 2019).